Results 21 to 30 of about 8,271,373 (199)

Plasma Cell-Free DNA in Patients with Diffuse Large B-Cell and B-Cell High-Grade (Double Hit/Triple Hit) Lymphomas

open access: yesКлиническая онкогематология, 2023
Aim. To study plasma cell-free DNA (pcfDNA) concentration and B-cell clonality in patients with diffuse large B-cell (DLBCL) and B-cell high-grade lymphomas prior to and at different stages of chemotherapy as well as the correlation between the data ...
Svetlana Yurevna Smirnova   +8 more
doaj   +1 more source

T-Helper Subpopulations in Acute Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation

open access: yesКлиническая онкогематология, 2023
Aim. To identify the characteristics of T-helper subpopulations in healthy donors and to compare them with those reported in acute leukemia patients 6 months after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Yuliya Olegovna Davydova   +9 more
doaj   +1 more source

Microsphere-assisted, nanospot, non-destructive metrology for semiconductor devices

open access: yesLight: Science & Applications, 2022
As smaller structures are being increasingly adopted in the semiconductor industry, the performance of memory and logic devices is being continuously improved with innovative 3D integration schemes as well as shrinking and stacking strategies.
Soonyang Kwon   +4 more
doaj   +1 more source

Cytogenetic and Molecular Genetic Abnormalities of CIITA Gene in Patients with Primary Mediastinal (Thymic) Large B-Cell Lymphoma

open access: yesКлиническая онкогематология, 2021
Background. Primary mediastinal (thymic) large B-cell lymphoma (PMBCL) is an aggressive malignant lymphoproliferative disease which accounts for 2–3 % of all non-Hodgkin’s lymphomas.
Svetlana Aleksandrovna Kuznetsova   +9 more
doaj   +1 more source

Identification of Somatic Mutations in EZH2 Gene and Assessment of Their Prognostic Value in Follicular Lymphoma Grades 1–3А

open access: yesКлиническая онкогематология, 2023
Aim. To determine the incidence and prognostic value of mutations in exon 16 of EZH2 as well as those of polymorphism с.1582-21А>G (rs2072407) in EZH2 in patients with follicular lymphoma (FL) grades 1–3А in relation to morphologic and cytogenetic tumor ...
Ekaterina Sergeevna Nesterova   +10 more
doaj   +1 more source

Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

open access: yesКлиническая онкогематология, 2023
Aim. To determine the prognostic value of t(14;18)(q32;q21) in follicular lymphoma (FL) of grades 1–3А, to assess the chemotherapy efficacy in “t(14;18)+ FL” and “t(14;18)– FL” patients, and to analyze the cases of ineffective therapy.
Ekaterina Sergeevna Nesterova   +10 more
doaj   +1 more source

Risk Factors for Rehospitalizations after Allogeneic Hematopoietic Stem Cell Transplantation

open access: yesКлиническая онкогематология, 2020
Aim. To assess the rehospitalization data of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT), to determine possible risk factors for rehospitalization, and to work out a strategy of post-transplantation follow-up for this ...
Mikhail Yur’evich Drokov   +8 more
doaj   +1 more source

Dynamics of SARS-CoV-2 RNA Detection in Patients and Employees of the National Research Center for Hematology During the First Two Years of the Novel COVID-19 Pandemic

open access: yesКлиническая онкогематология, 2023
Background. COVID-19 required fundamental changes in healthcare management, also in medical care for oncological and hematological patients. Visits to healthcare organizations were minimized, 75 % of doctor appointments were converted to telemedicine ...
Oksana Gazimagomedovna Starkova   +7 more
doaj   +1 more source

Bridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks.
Charlotte N. Stahlfeld   +5 more
wiley   +1 more source

Experience with the Use of B-RAF Inhibitor Vemurafenib in the Treatment of Hairy Cell Leukemia

open access: yesКлиническая онкогематология, 2022
Background. The standard and effective treatment of hairy cell leukemia (HCL) involves purine analogs, interferon-α (IFN-α) administration, and splenectomy.
L. S. Al-Radi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy